University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer ...

A new formulation of the drug paclitaxel may help overcome some common limitations of chemotherapy drugs, setting the stage ...

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb Company is ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...

Treatment with a paclitaxel-coated balloon led to better outcomes in patients with multilayer in-stent restenosis compared with conventional balloon angioplasty.

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...

Paclitaxel-coated balloon (PCB) angioplasty had similar long-term outcomes as repeat stenting with a drug-eluting stent (DES) in patients with DES in-stent chronic total occlusion (IS-CTO).